The markets recovered earlier losses to trade mixed during the midday with the Dow slipping 6 points to 15,632 as the nation's services sector expanded more than expected in October. Nasdaq added 4 points 3941.
On the upside
Oxygen Biotherapeutics (Nasdaq: OXBT) was identified as a Barbarian at the Gate stock by Trade-Ideas.
Keryx Biopharmaceuticals (Nasdaq: KERX) reported positive results from midstage clinical trial of its chronic kidney disease treatment Zerenex.
Michael Kors (NYSE: KORS) impressed with sharply higher second quarter earnings and revenue that beat analyst expectations.
On the downside
Dex Media (Nasdaq: DXM) widened third quarter losses.
Piper Jaffray suspended its rating on NQ Mobile (NYSE: NQ).
Hertz Global (NYSE: HTZ) reported lower third quarter earnings.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 slipped 2 points to 1765.
